Overview

GMP compliant production focuses on the production of high-quality gene vectors and gene therapy medicinal products that support both clinical trials and commercial production. The services are designed to develop genetic treatments by providing a scalable, safe and reproducible production solution that reduces development risks and speeds up the time line to reach the market.

Who benefits?

The services are suitable for biotechnology companies, pharmaceutical companies, research laboratories and start-up teams that require reliable production of gen vectors for the clinical development and placing on the market stage. For those who develop gen therapeutic medicinal products and need a GMP-standard partner throughout the process.

Why choose this solution

• High purity and stability - strict cleaning and control methods ensure the biological purity and stability of the product.
• Regular preparation - processes and documentation are in line with GMP requirements, facilitating regulatory approaches and approvals.
• - from small-volume clinical batches to high-volume commercial production to support growth without compromise of quality
<Analy & quality control - advanced analytical Adjusted processes reduce batch variation and increase the efficiency of production, which gives a competitive advantage in terms of time and cost savings.

Value for business

Investment in GMP-oriented production reduces the risks of further development, speeds up regulatory approvals and improves investor confidence. The combination of purity, stability and comprehensive quality control helps to achieve better clinical results and shorter time to reach the market.

How to start

The first step is the initial technical evaluation of cooperation: batch requirements, vector type and regulatory targets. The adapted production and qualification plan will then be followed, leading to clinical or commercial production through common control points.

In short: well thought-out process development, GMP-compliant production and strong analysis will provide a sound basis for the successful development and placing on the market of genetic treatments.